Nausea and emesis: still an unsolved problem in cancer patients?
- PMID: 11862497
- DOI: 10.1007/s00520-001-0339-7
Nausea and emesis: still an unsolved problem in cancer patients?
Similar articles
-
Concomitants of anticipatory nausea and emesis in cancer patients in chemotherapy.Psychol Rep. 1985 Apr;56(2):671-6. doi: 10.2466/pr0.1985.56.2.671. Psychol Rep. 1985. PMID: 4001271 No abstract available.
-
[Nausea and vomiting].Nihon Rinsho. 2003 Jun;61(6):954-8. Nihon Rinsho. 2003. PMID: 12806942 Review. Japanese.
-
Controlling emesis: what is it worth?J Clin Oncol. 2006 Dec 10;24(35):5617; author reply 5616-7. doi: 10.1200/JCO.2006.08.3238. J Clin Oncol. 2006. PMID: 17158553 No abstract available.
-
Scopolamine for cancer-related nausea and vomiting.J Pain Symptom Manage. 2010 Jul;40(1):136-41. doi: 10.1016/j.jpainsymman.2009.12.008. J Pain Symptom Manage. 2010. PMID: 20619216
-
Olanzapine for nausea and vomiting.Am J Hosp Palliat Care. 2010 Sep;27(6):432-4. doi: 10.1177/1049909110369532. Epub 2010 May 27. Am J Hosp Palliat Care. 2010. PMID: 20508243 Review.
Cited by
-
Cost-effectiveness of aprepitant in Japanese patients treated with cisplatin-containing highly emetogenic chemotherapy.Cancer Sci. 2018 Sep;109(9):2881-2888. doi: 10.1111/cas.13736. Epub 2018 Aug 3. Cancer Sci. 2018. PMID: 29999572 Free PMC article. Clinical Trial.
-
Phase II study of fosaprepitant + 5HT3 receptor antagonist + dexamethasone in patients with germ cell tumors undergoing 5-day cisplatin-based chemotherapy: a Hoosier Cancer Research Network study.Support Care Cancer. 2016 Jul;24(7):2837-42. doi: 10.1007/s00520-016-3100-y. Epub 2016 Feb 2. Support Care Cancer. 2016. PMID: 26838019 Clinical Trial.
-
Impact of adherence to antiemetic guidelines on the incidence of chemotherapy-induced nausea and vomiting and quality of life.Int J Clin Pharm. 2016 Dec;38(6):1464-1476. doi: 10.1007/s11096-016-0393-3. Epub 2016 Oct 28. Int J Clin Pharm. 2016. PMID: 27796777
-
End-of-life care of women with gynecologic malignancies: a pilot study.Int J Gynecol Cancer. 2013 Mar;23(3):546-52. doi: 10.1097/IGC.0b013e3182842efa. Int J Gynecol Cancer. 2013. PMID: 23429487 Free PMC article.
-
Cost-utility analysis of aprepitant for patients who truly need it in Japan.Support Care Cancer. 2019 Oct;27(10):3749-3758. doi: 10.1007/s00520-019-04672-w. Epub 2019 Feb 1. Support Care Cancer. 2019. PMID: 30710243
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical